BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Drug Development

  ViroPharma Incorporated and Halozyme Therapeutics, Inc. Announce Positive Data of Subcutaneous Cinryze® (C1 esterase inhibitor [human]) With Recombinant Human Hyaluronidase (rHuPH20)

  March 6, 2012

   · 

  12 min read
• Jazz Pharmaceuticals, Inc. Falls on Offering of 7.88 Million Shares

  March 6, 2012

   · 

  3 min read
• Business

  Medgenics, Inc. Announces 2011 Financial Results

  March 6, 2012

   · 

  1 min read
• Drug Development

  MorphoSys AG Completes Enrollment in MOR103 Phase 1b/2a Rheumatoid Arthritis Trial

  March 6, 2012

   · 

  4 min read
• Biotech Bay

  Threshold Pharmaceuticals, Inc. Announces Oral Presentation on TH-302 Clinical Study at the 2012 American Association for Cancer Research Annual Meeting

  March 6, 2012

   · 

  4 min read
• Business

  Dynavax Technologies Corporation Reports Fourth Quarter and Year End 2011 Financial Results

  March 6, 2012

   · 

  7 min read
• BioForest

  SCOLR Pharma, Inc. Provides Product Information on Website

  March 6, 2012

   · 

  1 min read
• Business

  Synteract, Inc. (San Diego) Expands Executive Roles to Support Growth

  March 6, 2012

   · 

  3 min read
• Pharm Country

  Proteonomix, Inc. (PROT) Announces a Private Placement of $3.8 Million

  March 6, 2012

   · 

  4 min read
• Pharm Country

  ConMed Corporation Sets Annual Meeting Date

  March 6, 2012

   · 

  1 min read